- Home
- ARDX vs HSTM Comparison
ARDX vs HSTM Comparison
Compare ARDX & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- HSTM
- Stock Information
- Founded
- ARDX 2007
- HSTM 1990
- Country
- ARDX United States
- HSTM United States
- Employees
- ARDX N/A
- HSTM N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- HSTM Computer Software: Programming Data Processing
- Sector
- ARDX Health Care
- HSTM Technology
- Exchange
- ARDX Nasdaq
- HSTM Nasdaq
- Market Cap
- ARDX 882.9M
- HSTM 734.2M
- IPO Year
- ARDX 2014
- HSTM 2000
- Fundamental
- Price
- ARDX $5.57
- HSTM $24.66
- Analyst Decision
- ARDX Strong Buy
- HSTM Hold
- Analyst Count
- ARDX 10
- HSTM 2
- Target Price
- ARDX $10.65
- HSTM $28.00
- AVG Volume (30 Days)
- ARDX 4.4M
- HSTM 188.3K
- Earning Date
- ARDX 10-30-2025
- HSTM 11-03-2025
- Dividend Yield
- ARDX N/A
- HSTM 0.50%
- EPS Growth
- ARDX N/A
- HSTM 4.75
- EPS
- ARDX N/A
- HSTM 0.68
- Revenue
- ARDX $398,234,000.00
- HSTM $298,590,000.00
- Revenue This Year
- ARDX $18.90
- HSTM $4.91
- Revenue Next Year
- ARDX $31.52
- HSTM $5.11
- P/E Ratio
- ARDX N/A
- HSTM $36.26
- Revenue Growth
- ARDX 58.12
- HSTM 3.68
- 52 Week Low
- ARDX $3.21
- HSTM $24.07
- 52 Week High
- ARDX $6.78
- HSTM $34.24
- Technical
- Relative Strength Index (RSI)
- ARDX 52.45
- HSTM 34.62
- Support Level
- ARDX $5.59
- HSTM $24.07
- Resistance Level
- ARDX $6.73
- HSTM $27.31
- Average True Range (ATR)
- ARDX 0.30
- HSTM 0.85
- MACD
- ARDX 0.09
- HSTM -0.06
- Stochastic Oscillator
- ARDX 35.44
- HSTM 12.96
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.